Coronavirus: Despite getting the Covid-19 vaccination, in most cases vulnerable to infection, the cause of infection is the delta from of the coronavirus.
New Delhi. The Delta variant of Coronavirus remains dangerous in India. According to the Indian SARS CoV2 Genomics Consortium (INSACOG), recent genome sequencing of samples taken from different parts of the country has shown that delta variants continue to be responsible for the infection. Due to this, new corona infection (Covid 19 in India) cases are increasing. However, research has also revealed that vaccination is providing a high degree of protection against coronavirus.
At the same time, despite getting the Kovid-19 vaccination, in most cases vulnerable to infection, the cause of infection is the delta from of the coronavirus. However, only 9.8 percent of such cases required hospitalization and the mortality rate was also 0.4 percent. This has been revealed in a new study by the Indian Council of Medical Research (ICMR). Infection after vaccination is called 'breakthrough infection'. This is the largest and first nationwide study to investigate the cases of 'Breakthrough Infection' ie post-vaccination infection in India.
Insacog says that vaccination is more important. Along with the use of face masks, social distancing, as well as other rules of prevention from corona, should also be adopted. According to him, delta variants are the main reason for increasing cases of coronavirus infection in many countries outside India. For example, Southeast Asia is seeing the largest increase in new cases of coronavirus globally. However, countries with more vaccinations such as Singapore are doing better against this infection.
According to the American organization CDC, delta variants have been found in 83 percent of the total samples sequenced for America Kovid 19. Let us inform you that a total of 41.76 crore doses of the Covid-19 vaccine have been given in the country.
More than 20.83 lakh doses of vaccine have been given on Wednesday. On Wednesday, 10,04,581 beneficiaries in the age group of 18 to 44 years were given the first dose and 95,964 were given the second dose, the ministry said.